Paper29456015
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
John S and 6 others. Vaccine, 2018. Cited by 176 papers, by iCite.
Cite this record
ConductScience Library. Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity. Papers, record 29456015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29456015
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytomegalovirus | Major topic |
| Cytomegalovirus Infections | Major topic |
| Cytomegalovirus Vaccines | Major topic |
| Immunity, Cellular | Major topic |
| Immunity, Humoral | Major topic |
| Vaccines, Synthetic | Major topic |
| Animals | |
| Antibodies, Neutralizing | |
| Antibodies, Viral | |
| Cell Line | |
| Cytokines | |
| Female | |
| Gene Expression | |
| Humans | |
| Mice | |
| Neutralization Tests | |
| T-Lymphocytes | |
| Vaccination |
Source PubMed
Cited by140
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 176 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42844249 | Bioengineering strategies for improving the immunogenicity of mRNA vaccines. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42844249 | PubMed |
| 42460750 | Cancer Vaccine Development: Toward Artificial Intelligence-Assisted Personalized Cell Membrane Nanovaccine. | Small | 2026 | https://conductscience.org/library/papers/42460750 | PubMed |
| 42439560 | Functional dissection of HCMV gB's autonomous fusion activity provides insights into how polymorphisms in clinical isolates confer distinct characteristics. | mBio | 2026 | https://conductscience.org/library/papers/42439560 | PubMed |
| 42188814 | Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188814 | PubMed |
| 42081324 | Enhanced immunogenicity and dose-sparing efficacy of self-amplifying RNA vaccines against seasonal influenza across subtypes. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42081324 | PubMed |
| 41962202 | Recent advances in LNP-mRNA vaccines. | Colloids Surf B Biointerfaces | 2026 | https://conductscience.org/library/papers/41962202 | PubMed |
| 41710557 | Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions. | In Vitro Model | 2025 | https://conductscience.org/library/papers/41710557 | PubMed |
| 41600815 | Elements of Viral Outbreak Preparedness: Lessons, Strategies, and Future Directions. | Viruses | 2025 | https://conductscience.org/library/papers/41600815 | PubMed |
| 41285802 | mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset. | Nat Commun | 2025 | https://conductscience.org/library/papers/41285802 | PubMed |
| 41266455 | To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/41266455 | PubMed |
| 41179708 | mRNA Vaccines: Current Applications and Future Directions. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41179708 | PubMed |
| 41059491 | Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41059491 | PubMed |
| 41020145 | Vaccines as Potential Frontliners Against Antimicrobial Resistance (AMR): A Focused Review. | Infect Drug Resist | 2025 | https://conductscience.org/library/papers/41020145 | PubMed |
| 40990374 | Specificity and functional humoral immune responses induced by the VBI-1501A eVLP HCMV gB vaccine compared to the gB/MF59 vaccine. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40990374 | PubMed |
| 40873637 | Exploring the Potential and Advancements of Circular RNA Therapeutics. | Exploration (Beijing) | 2025 | https://conductscience.org/library/papers/40873637 | PubMed |
| 40855125 | A modular vaccine platform for optimized lipid nanoparticle mRNA immunogenicity. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/40855125 | PubMed |
| 40730746 | A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40730746 | PubMed |
| 40589473 | Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation. | Front Med Technol | 2025 | https://conductscience.org/library/papers/40589473 | PubMed |
| 40518670 | mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models. | Mol Ther | 2025 | https://conductscience.org/library/papers/40518670 | PubMed |
| 40338082 | A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice. | J Virol | 2025 | https://conductscience.org/library/papers/40338082 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29456015
GET https://conductscience.org/api/papers/v1/29456015/cited_by?page=2